Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board
Stock Information for CorMedix Inc.
Loading
Please wait while we load your information from QuoteMedia.